Sunbaxy - The New IPM Dynamics A. Sun is ranked No 1 in two - TopicsExpress



          

Sunbaxy - The New IPM Dynamics A. Sun is ranked No 1 in two super groups. With the buyout they rank No 1 in 4 supergroups. B. Sun is ranked at No 1 in two regions. The combined entity would rank No 1 in 15 regions. C. Sun would now be a dominant player in Anti-infective market due to Ranbaxy portfolio. D. Combined entity would cross 1000 Crs in 2 supergroups - Neuro/CNS & Cardiac. E. Combined entity moves to No 1 in Gynaec Market. F. 4 Brands more than 100 Crs with a foothold in OTC. G. Combined entity would have 32 Brands in Top 300 Brands. Source: AIOCD Pharmasofttech AWACS
Posted on: Mon, 14 Apr 2014 06:05:02 +0000

Trending Topics



Recently Viewed Topics




© 2015